Evaluation of Aminohydantoins as a Novel Class of Antimalarial Agents
摘要:
Given the threat of drug resistance, there is an acute need for new classes of antimalarial agents that act via a unique mechanism of action relative to currently used drugs. We have identified a set of druglike compounds within the Tres Cantos Anti-Malarial Set (TCAMS) which likely act via inhibition of a Plasmodium aspartic protease. Structure-activity relationship analysis and optimization of these aminohydantoins demonstrate that these compounds are potent nanomolar inhibitors of the Plasmodium aspartic proteases PM-II and PM-IV and likely one or more other Plasmodium aspartic proteases. Incorporation of a bulky group, such as a cyclohexyl group, on the aminohydantion N-3 position gives enhanced antimalarial potency while reducing inhibition of human aspartic proteases such as BACE. We have identified compound 8p (CWHM-117) as a promising lead for optimization as an antimalarial drug with a low molecular weight, modest lipophilicity, oral bioavailability, and in vivo antimalarial activity in mice.
CO<sub>2</sub>-assisted synthesis of non-symmetric α-diketones directly from aldehydes<i>via</i>C–C bond formation
作者:Pradipbhai Hirapara、Daniel Riemer、Nabanita Hazra、Jignesh Gajera、Markus Finger、Shoubhik Das
DOI:10.1039/c7gc02425h
日期:——
CO2-assisted various symmetric and non-symmetric α-diketones have been synthesized directly from the corresponding aldehydes using transition metal-free catalysts. This method can even be applied to synthesize pharmaceuticals directly from aldehydes. The crucial role of CO2 has been investigated in detail and the mechanism is proposed on the basis of experiments and DFT calculations.
COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALARIA
申请人:Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
公开号:US20140296532A1
公开(公告)日:2014-10-02
The present invention provides aminohydantoin anti-malarial agents. In some embodiments, these agents have the property of functions of targeting malarial aspartic proteases while at the same time having low activity against human BACE. Methods of employing such agents are also provided.
[EN] COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALARIA<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE LA MALARIA
申请人:UNIV SAINT LOUIS
公开号:WO2014160775A1
公开(公告)日:2014-10-02
The present invention provides aminohydantoin anti-malarial agents. In some embodiments, these agents have the property of functions of targeting malarial aspartic proteases while at the same time having low activity against human BACE. Methods of employing such agents are also provided.